Prostaglandin-E-producing hepatocellular carcinoma with hypercalcemia.

Abstract:

:An autopsy case of prostaglandin E-producing hepatocellular carcinoma with hypercalcemia is presented in this article. A 72-year-old man showed high serum calcium levels (14.2 to 17.3 mg/100 ml) and hypophosphatemia. The plasma level of immunoreactive parathyroid hormone was below the normal range. Administration of oral indomethacin 50 mg daily was effective in decreasing the serum calcium concentration. However, this effect lasted only 5 days, after which it returned to pretreatment levels. The patient died in a hypercalcemic coma. By an autopsy, hepatocellular carcinoma was found in the right lobe of the liver. However, no obvious bone metastases nor abnormalities in the parathyroid glands were detected. The immunoreactive prostaglandin E level assayed in the neoplastic tissue (2278 ng/g) was significantly high when compared with level in the nonneoplastic liver tissue (194 ng/g). The production of prostaglandin E by the tumor itself appears to be the most likely mechanism for the hypercalcemia in this patient.

journal_name

Cancer

journal_title

Cancer

authors

Ikeda T,Tozuka S,Hasumura Y,Takeuchi J

doi

10.1002/1097-0142(19880501)61:9<1813::aid-cncr2820

subject

Has Abstract

pub_date

1988-05-01 00:00:00

pages

1813-4

issue

9

eissn

0008-543X

issn

1097-0142

journal_volume

61

pub_type

杂志文章

相关文献

CANCER文献大全
  • Conditional median survival of patients with advanced carcinoma: surveillance, epidemiology, and end results data.

    abstract:BACKGROUND:Conditional survival is clinically useful, particularly for patients with malignant disease who have a poor prognosis. However, there are no published data on the conditional median survival of patients with advanced carcinoma on a population basis. METHODS:Data on 217,573 patients with breast, colorectal, ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20011015)92:8<2211::aid-cncr1565

    authors: Kato I,Severson RK,Schwartz AG

    更新日期:2001-10-15 00:00:00

  • Transformation of Hodgkin's disease into malignant fibrous histiocytoma.

    abstract::The continuity that exists between Hodgkin's disease and the fibrohistiocytoses has only recently been recognized. Four cases are presented that illustrate this phenomenon. The fibrohistiocytic component of the Hodgkin's lesion may lag behind the lymphoreticular component, may be present in equal proportion, or may as...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860115)57:2<264::aid-cncr28205

    authors: Suster S

    更新日期:1986-01-15 00:00:00

  • Clear cell carcinoma of the uterine endocervix with an in situ component.

    abstract::In the past all clear cell carcinomas of the female genital tract were thought to arise from mesonephric remnants. Recently increasing evidence has related their origin to müllerian rather than mesonephric epithelium. One of the main reasons that has been advanced to support their mesonephric origin has been their occ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197811)42:5<2435::aid-cncr282042

    authors: Hasumi K,Ehrmann RL

    更新日期:1978-11-01 00:00:00

  • Prolonged intermittent adjuvant chemotherapy with CCNU and hydroxyurea after resection of carcinoma of the lung.

    abstract::Eight hundred sixty-five patients with a microscopically curative resection for carcinoma of the lung were accepted for study, none of whom were excluded from analysis. Adjuvant therapy was randomly assigned about the tenth to 14th postoperative day; 432 patients (treated) were to receive CCNU and hydroxyurea for one ...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(19821101)50:9<1713::aid-cncr2820

    authors: Shields TW,Higgins GA Jr,Humphrey EW,Matthews MJ,Keehn RJ

    更新日期:1982-11-01 00:00:00

  • Adenoid cystic carcinoma of the salivary gland. Sustained complete response to chemotherapy.

    abstract::A patient developed widely metastatic adenoid cystic carcinoma of the parotid gland after several local recurrences. A complete regression of pleural, pulmonary parenchymal, cutaneous, and bone metastases was seen following therapy with 5-fluorouracil, Adriamycin, and mitomycin C. This is the second complete response ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19830215)51:4<589::aid-cncr28205

    authors: Budd GT,Groppe CW

    更新日期:1983-02-15 00:00:00

  • The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy.

    abstract:BACKGROUND:Results from numerous trials have indicated that breast-conserving therapy (BCT) produces outcomes equivalent to those produced by mastectomy in terms of both locoregional control and survival. However, conservative treatment has resulted in the dilemma of how best to address recurrences when they appear in ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.22529

    authors: Vicini FA,Antonucci JV,Goldstein N,Wallace M,Kestin L,Krauss D,Kunzmann J,Gilbert S,Schell S

    更新日期:2007-04-01 00:00:00

  • Infiltrating lobular carcinoma of the female breast. Deviations from the usual histopathologic appearance.

    abstract::Twenty-two cases of breast tumor with infiltrating lobular carcinoma were studied. Thirteen showed the classic single-file pattern as a sole component, and 6 as a predominant pattern; the less common confluent pattern was found in 3 instances as a predominant component. Mucin secretion was evidenced in 59% of the prim...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800301)45:5<979::aid-cncr28204

    authors: Van Bogaert LJ,Maldague P

    更新日期:1980-03-01 00:00:00

  • Latent Epstein-Barr virus infection is an unlikely event in the pathogenesis of immunoproliferative small intestinal disease.

    abstract:BACKGROUND:The observed seasonal and geographic variations in the incidence of immunoproliferative small intestinal disease (IPSID) suggest that environmental factors contribute to its pathogenesis. One such environmental factor, the Epstein-Barr virus (EBV), has been associated with other B-cell lymphoproliferative di...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19940915)74:6<1699::aid-cncr2820

    authors: Baddoura FK,Unger ER,Mufarrij A,Nassar VH,Zaki SR

    更新日期:1994-09-15 00:00:00

  • Enhancement of chemotherapeutic effects by recombinant human granulocyte colony-stimulating factor on implanted mouse bladder cancer cells (MBT-2).

    abstract::Recombinant human granulocyte colony-stimulating factor (rhG-CSF) was administered intraperitoneally in combination with multidrug chemotherapy using methotrexate (M), vinblastine (V), doxorubicin (A), and cisplatin (C, or for the combination, MVAC) to C3H/He mice (5-week-old females) after experimental carcinoma, MBT...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19920215)69:4<997::aid-cncr28206

    authors: Akaza H,Fukushima H,Koiso K,Aso Y

    更新日期:1992-02-15 00:00:00

  • Risk assessment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates: a historical cohort study.

    abstract:BACKGROUND:The mortality rate associated with fever accompanied by pulmonary infiltrates after chemotherapy for hematologic malignancies remains higher than the corresponding rate associated with febrile neutropenia without pulmonary infiltrates. Nonetheless, few studies have focused on the factors that predict outcome...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20406

    authors: Offidani M,Corvatta L,Malerba L,Marconi M,Bichisecchi E,Cecchini S,Manso E,Principi T,Gasparini S,Leoni P

    更新日期:2004-08-01 00:00:00

  • Complementary therapies in palliative cancer care.

    abstract:BACKGROUND:Complementary medicine has become an important aspect of palliative cancer care. This overview is primarily aimed at providing guidance to clinicians regarding some commonly used complementary therapies. METHODS:Several complementary therapies were identified as particularly relevant to palliative cancer ca...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(20010601)91:11<2181::aid-cncr124

    authors: Ernst E

    更新日期:2001-06-01 00:00:00

  • Female adnexal tumor of probable Wolffian origin with multiple recurrences over 16 years.

    abstract::The case history of a woman with a "female adnexal tumor of probable Wolffian origin" is described in which the neoplasm recurred three times during a 16-year interval and responded with prolonged remission after repeated surgical excision and radiotherapy. Ultrastructural data are given to support the Wolffian nature...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850915)56:6<1456::aid-cncr2820

    authors: Brescia RJ,Cardoso de Almeida PC,Fuller AF Jr,Dickersin GR,Robboy SJ

    更新日期:1985-09-15 00:00:00

  • Reduced C-terminal Src kinase activity is correlated inversely with pp60(c-src) activity in colorectal carcinoma.

    abstract:BACKGROUND:Specific kinase activity of the proto-oncogene product pp60(c-src) is reported to be elevated in patients with carcinoma of the colon, and a novel cytoplasmic protein-tyrosine kinase, C-terminal Src kinase (Csk), has been found to inactivate the members of the Src family protein-tyrosine kinase. In this stud...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20010701)92:1<61::aid-cncr1292>3

    authors: Cam WR,Masaki T,Shiratori Y,Kato N,Ikenoue T,Okamoto M,Igarashi K,Sano T,Omata M

    更新日期:2001-07-01 00:00:00

  • A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer.

    abstract:BACKGROUND:Sunitinib has replaced interferon (IFN) as a first-line standard of care in the treatment of metastatic renal cell carcinoma (RCC). This study aimed to determine overall survival and to confirm effectiveness in a population that includes poor prognosis patients. METHODS:Data were collected on all patients i...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24051

    authors: Heng DY,Chi KN,Murray N,Jin T,Garcia JA,Bukowski RM,Rini BI,Kollmannsberger C

    更新日期:2009-02-15 00:00:00

  • Investigation of taxol as a potential radiation sensitizer.

    abstract:BACKGROUND:The authors evaluated the effects of taxol, a microtubular inhibitor, as a possible radiation sensitizer on the human leukemic cell line (HL-60). Taxol acts as a mitotic inhibitor, blocking cells in the G2M-phase of the cell cycle. The differential radiation sensitivity of cells in various phases of the cell...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19930601)71:11<3774::aid-cncr282

    authors: Choy H,Rodriguez FF,Koester S,Hilsenbeck S,Von Hoff DD

    更新日期:1993-06-01 00:00:00

  • Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: long-term results of CALGB 99809.

    abstract:BACKGROUND:Combined transperineal prostate brachytherapy and external beam radiation therapy (EBRT) is widely used for treatment of prostate cancer. Long-term efficacy and toxicity results of a multicenter phase 2 trial assessing combination of EBRT and transperineal prostate brachytherapy boost with androgen deprivati...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.26203

    authors: Hurwitz MD,Halabi S,Archer L,McGinnis LS,Kuettel MR,DiBiase SJ,Small EJ

    更新日期:2011-12-15 00:00:00

  • A comparative study of copper-67 radiolabeling and kinetic stabilities of antibody-macrocycle chelate conjugates.

    abstract:BACKGROUND:The development of new chelating agents and radiolabeling protocols is essential to progress in radioimmunotherapy with antibody-chelate conjugates. METHODS:Immunoconjugates of four polyazamacrocycles with N-bonded acetate groups were prepared by conjugation via 2-iminothiolane to Lym-1, a murine antilympho...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19940201)73:3+<779::aid-cncr2820

    authors: Kukis DL,Diril H,Greiner DP,DeNardo SJ,DeNardo GL,Salako QA,Meares CF

    更新日期:1994-02-01 00:00:00

  • Antitumor electrochemotherapy: new advances in the clinical protocol.

    abstract:BACKGROUND:Electrochemotherapy (ECT) is a new antitumor approach that combines systemic bleomycin (BLM) with electric pulses (EP) delivered locally at the tumor site. These EP permeabilize the cells in the tissue, allow BLM delivery inside the cells, and increase BLM cytotoxicity. As an extension of our initial Phase I...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/(sici)1097-0142(19960301)77:5<956::aid-cnc

    authors: Domenge C,Orlowski S,Luboinski B,De Baere T,Schwaab G,Belehradek J Jr,Mir LM

    更新日期:1996-03-01 00:00:00

  • Correlation between genetic alteration and long-term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p.

    abstract:BACKGROUND:In oligodendroglial tumors, allelic losses on chromosome arms 1p and 19q are not only diagnostic molecular markers but also statistically significant predictors of both chemosensitivity and longer recurrence-free survival. In the current study, the authors attempted to analyze 21 patients genetically and cli...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11322

    authors: Hashimoto N,Murakami M,Takahashi Y,Fujimoto M,Inazawa J,Mineura K

    更新日期:2003-05-01 00:00:00

  • Phase I study of escalating doses of mitoxantrone and paclitaxel with granulocyte-macrophage colony stimulating factor support.

    abstract:BACKGROUND:Both paclitaxel and mitoxantrone demonstrate significant antineoplastic activity in breast cancer patients. Colony stimulating factor support allows significant dose escalation of each of these drugs when administered as a single agent. METHODS:We performed a Phase I study employing escalating doses of pacl...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/(SICI)1097-0142(19960601)77:11<2308::AID-C

    authors: Fleming GF,Janisch L,Vogelzang NJ,Vokes EE,Ratain MJ

    更新日期:1996-06-01 00:00:00

  • Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.

    abstract:BACKGROUND:Inactivation of the tumor suppressor gene PTEN/MMAC1/TEP1, located on chromosome 10q23, is a common event in advanced stages of diverse human malignancies. However, the prognostic role of PTEN expression in patients with hepatocellular carcinoma (HCC) has not been characterized. METHODS:One hundred five res...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11266

    authors: Hu TH,Huang CC,Lin PR,Chang HW,Ger LP,Lin YW,Changchien CS,Lee CM,Tai MH

    更新日期:2003-04-15 00:00:00

  • Medical oncology and geriatric medicine: is it time for fellowship integration?

    abstract::Although training programs exist in both medical oncology and geriatrics (approved by the American Board of Internal Medicine), neither is adequate to ensure an appropriate supply of physicians to assume a leadership role in the treatment of the increasing number of geriatric patients who have or will develop a malign...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19971001)80:7<1351::aid-cn

    authors: Bennett JM,Sahasrabudhe DM,Hall WJ

    更新日期:1997-10-01 00:00:00

  • Silent cirrhosis in patients with hepatocellular carcinoma. Implications for screening in high-incidence and low-incidence areas.

    abstract::We assessed the frequency of silent (i.e., clinically asymptomatic) cirrhosis among 305 patients with hepatocellular carcinoma (HCC) and cirrhosis in relation to the patients' country of birth, the cause of the cirrhosis, clinical features, and hepatitis B surface antigen (HBsAg) status. Overall, 56% of the patients h...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19900401)65:7<1607::aid-cncr2820

    authors: Zaman SN,Johnson PJ,Williams R

    更新日期:1990-04-01 00:00:00

  • Methodologic approaches to quality care evaluation.

    abstract::A number of problems inherent to quality of care evaluation have been described above. Although issues such as limited resources and clinical staff resistance may not be specific to cancer care, they certainly impact on the evaluation of the quality of care offered to cancer patients. Other issues such as complexity o...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890701)64:1+<302::aid-cncr2820

    authors: Miransky LJ

    更新日期:1989-07-01 00:00:00

  • Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors.

    abstract:BACKGROUND:A new, internationally accepted histologic classification of renal cell carcinoma (RCC) and a new edition of the TNM staging system were introduced in 1997. In the latter, there was a dramatic change in the pT classification of organ-confined renal cancer in which the break point between category pT1 and pT2...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Moch H,Gasser T,Amin MB,Torhorst J,Sauter G,Mihatsch MJ

    更新日期:2000-08-01 00:00:00

  • The Akt/mammalian target of rapamycin pathway is activated and associated with adverse prognosis in soft tissue leiomyosarcomas.

    abstract:BACKGROUND:The Akt/mammalian target of rapamycin (mTOR) pathway mediates cell survival and proliferation and contributes to tumor progression. Soft tissue leiomyosarcoma continues to show poor prognosis, and little is known about its mechanisms of tumor progression. Here the authors investigated the significance of act...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.26448

    authors: Setsu N,Yamamoto H,Kohashi K,Endo M,Matsuda S,Yokoyama R,Nishiyama K,Iwamoto Y,Dobashi Y,Oda Y

    更新日期:2012-03-15 00:00:00

  • Analysis of the presenting features of adult acute leukemia: the French-American-British classification.

    abstract::The authors have performed a clinical and statistical analysis of the presenting features of adult acute leukemia classified according to the French-American-British (FAB) hematopathologic criteria. Observations were made on 70 variables of history, physical examination, and laboratory examination recorded for 195 pat...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810515)47:10<2460::aid-cncr282

    authors: Burns CP,Armitage JO,Frey AL,Dick FR,Jordan JE,Woolson RF

    更新日期:1981-05-15 00:00:00

  • Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma.

    abstract:BACKGROUND:Central nervous system (CNS) recurrence is almost invariably fatal in patients with aggressive non-Hodgkin lymphoma (NHL). Although some protocols are intended to prevent CNS disease, the value of CNS prophylaxis in patients with aggressive NHL remains to be determined. METHODS:We retrospectively analyzed a...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.10699

    authors: Tomita N,Kodama F,Kanamori H,Motomura S,Ishigatsubo Y

    更新日期:2002-08-01 00:00:00

  • SARC025 arms 1 and 2: A phase 1 study of the poly(ADP-ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma.

    abstract:BACKGROUND:In preclinical Ewing sarcoma (ES) models, poly(adenosine diphosphate ribose) polymerase (PARP) inhibitors were identified as a potential therapeutic strategy with synergy in combination with cytotoxic agents. This study evaluated the safety and dosing of the PARP1/2 inhibitor niraparib (NIR) with temozolomid...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33349

    authors: Chugh R,Ballman KV,Helman LJ,Patel S,Whelan JS,Widemann B,Lu Y,Hawkins DS,Mascarenhas L,Glod JW,Ji J,Zhang Y,Reinke D,Strauss SJ

    更新日期:2020-12-08 00:00:00

  • Treatment burden and long-term health deficits of patients with low-grade gliomas or glioneuronal tumors diagnosed during the first year of life.

    abstract:BACKGROUND:Low-grade gliomas (LGGs) and low-grade glioneuronal tumors (LGGNTs) diagnosed during the first year of life carry unique clinical characteristics and challenges in management. However, data on the treatment burden, outcomes, and morbidities are lacking. METHODS:A retrospective study of LGGs and LGGNTs diagn...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31918

    authors: Liu APY,Hastings C,Wu S,Bass JK,Heitzer AM,Ashford J,Vestal R,Hoehn ME,Ghazwani Y,Acharya S,Conklin HM,Boop F,Merchant TE,Gajjar A,Qaddoumi I

    更新日期:2019-04-01 00:00:00